RecruitingNCT06096844
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
PHASE3 · 304 planned enrolment
- Countries listed
- 1
- Registry update
- October 7, 2026
Registry Intervention View
nab-paclitaxel
Trial registrations containing the exact intervention label nab-paclitaxel.
Exact registry label · Not reported
5 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
2 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT02812992
Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients
PHASE4 · 32 planned enrolment
- Countries listed
- 1
- Registry update
- August 10, 2021
CompletedNCT02151149
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
PHASE4 · 143 planned enrolment
- Countries listed
- 1
- Registry update
- September 24, 2018
TerminatedNCT02590003
Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer
PHASE2 · 3 planned enrolment
- Countries listed
- 1
- Registry update
- February 28, 2018
CompletedNCT02783222
EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer
PHASE2 · 160 planned enrolment
- Countries listed
- 1
- Registry update
- January 10, 2018